Requires 8 hour of fasting prior to test.
This is the recommended test for Hepatitis C status and liver damage.
It provides assessment of liver status following a diagnosis of HCV, as
well as baseline determination of liver status before initiating HCV
therapy. The test is also used for post-treatment assessment of liver
status six months after completion of therapy and noninvasive assessment
of liver status in patients who are at increased risk of complications
from a liver biopsy.
The Hepatitis C Virus (HCV) FibroSURE test includes:
FibroTest (α2-macroglobulin, haptoglobin, apo lipoprotein A1,
bilirubin, γ-glutamyl transpeptidase [GGT]); Acti Test
(α2-macroglobulin, haptoglobin, apolipoprotein A1, bili rubin,
γ-glutamyl transpeptidase [GGT], alanine aminotransferase [ALT]).